TOP STORY Tests For Genes Don’t Predict Breast Cancer Better Studying genes linked to breast cancer may someday lead to better treatments, but they do little to improve a doctor’s ability to predict who is likely to develop a tumor, researchers reported. [Press release from Reuters discussing online prepublication in The New England Journal of Medicine]
|
|
CURRENT PUBLICATIONS LABORATORY RESEARCH Dose-Dependent Induction of Distinct Phenotypic Responses to Notch Pathway Activation in Mammary Epithelial Cells Researchers investigated the cellular basis for the heterogeneous responses to Notch pathway activation in 3D cultures of MCF-10A mammary epithelial cells. [Proc Natl Acad Sci U S A] Integrin-Linked Kinase has a Critical Role in ErbB2 Mammary Tumor Progression: Implications for Human Breast Cancer Here, researchers show that mammary epithelial disruption of integrin-linked kinase results in a profound block in mammary tumor induction. [Oncogene] Artemin is Estrogen Regulated and Mediates Antiestrogen Resistance in Mammary Carcinoma Researchers report that artemin (ARTN) is an estrogen-inducible gene. Meta-analysis of gene expression data sets showed that ARTN expression is positively correlated to estrogen receptor status in human mammary carcinoma. [Oncogene] Potential Prognostic Value of Heat-Shock Protein 90 in the Presence of Phosphatidylinositol-3-Kinase Overexpression or Loss of PTEN, in Invasive Breast Cancers Evaluating the expression of signaling molecule proteins from the mitogen-activated protein kinase pathway and the phosphatidylinositol-3-kinase pathway in invasive breast cancers may identify prognostic marker(s) associated with early relapse. [Breast Cancer Res] Ack1 Mediated AKT/PKB Tyrosine 176 Phosphorylation Regulates Its Activation Researchers have uncovered that growth factors binding to receptor tyrosine kinases lead to activation of a non-receptor tyrosine kinase, Ack1 (also known as ACK or TNK2), which directly phosphorylates AKT at an evolutionarily conserved tyrosine 176 in the kinase domain. [PLoS ONE] Transient Tumor-Fibroblast Interactions Increase Tumor Cell Malignancy by a TGF-Beta Mediated Mechanism in a Mouse Xenograft Model of Breast Cancer Here, researchers report a role for normal stroma fibroblasts in the progression of invasive tumors to metastatic tumors. [PLoS ONE] Common Germ-Line Polymorphism of C1QA and Breast Cancer Survival The purpose of this study was to investigate the association of single nucleotide polymorphism, rs172378, with expression of C1QA and breast cancer survival. [Br J Cancer] CLINICAL RESEARCH Performance of Common Genetic Variants in Breast-Cancer Risk Models The inclusion of newly discovered genetic factors modestly improved the performance of risk models for breast cancer. The level of predicted breast-cancer risk among most women changed little after the addition of currently available genetic information. [N Engl J Med] Breast Cancer Among the Oldest Old: Tumor Characteristics, Treatment Choices, and Survival Women 80 years and older have breast cancer characteristics similar to those of younger women yet receive less aggressive treatment and experience higher mortality from early-stage breast cancer. [J Clin Oncol] Radiation Exposure, the ATM Gene, and Contralateral Breast Cancer in the Women’s Environmental Cancer and Radiation Epidemiology Study Women who carry rare deleterious ATM missense variants and who are treated with radiation may have an elevated risk of developing contralateral breast cancer. [J Natl Cancer Inst] Analgesic Use and Sex Steroid Hormone Concentrations in Postmenopausal Women Prior epidemiologic studies suggest that regular use of analgesics may decrease risk of breast and ovarian cancer. Researchers explored possible hormone-mediated mechanisms for these associations by examining the relationship between use of aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, and acetaminophen and sex steroid hormone concentrations among 740 postmenopausal women in the Nurses’ Health Study. [Cancer Epidemiol Biomarkers Prev]
|
|
POLICY NEWS It’s The Law of The Land: Health Overhaul Signed Claiming a historic triumph that could define his presidency, a jubilant Barack Obama signed a massive, nearly $1 trillion health care overhaul that will for the first time cement insurance coverage as the right of every U.S. citizen and begin to reshape the way virtually all Americans receive and pay for treatment. [United States Congress] HHS Announces Additional $162 Million in Recovery Act Investment to Advance Widespread Meaningful Use of Health IT U.S. Department of Health and Human Services (HHS) Secretary Kathleen Sebelius announced awards to help states facilitate health information exchange and advance health information technology (Health IT). [The Department of Health and Human Services, United States] Instructions for Completion and Peer Review of the Vertebrate Animal Section in NIH Grant Applications and Cooperative Agreements (NOT-OD-10-027) [National Institutes of Health, United States] Recovery Act: Update on American Recovery and Reinvestment Act Quarterly Reporting Requirements for Non-Competing Continuation Awards and Relinquished Projects; and Guidance to Avoid Common Errors (NOT-OD-10-065) [National Institutes of Health, United States] Recovery Act: Reminders on Annual Reporting Requirements and Notice of Revised Financial Closeout Requirements for American Recovery and Reinvestment Act-Funded Administrative Supplements and Competitive Revisions (NOT-OD-10-066) [National Institutes of Health, United States] Recovery Act: Notice on the Proper Management of Recovery Act Spending to Promote Job Creation and Increase the Pace of Scientific Research; and Policy Limiting Second No-Cost Extensions to Recovery Act Grants (NOT-OD-10-067) [National Institutes of Health, United States] Amended NIH Policy on Submission of Late Grant Application Materials Prior to Initial Peer Review (NOT-OD-10-070) [National Institutes of Health, United States] Modification: This Notice modifies RFA-RM-10-001 (NOT-RM-10-005) [National Institutes of Health, United States] Modification to RFA-RM-09-019: Institutional Clinical and Translational Science Award (U54) (NOT-RM-10-006) [National Institutes of Health, United States]
|
|
EVENTS 34th Annual Symposium of the American Society of Breast Disease (ASBD) April 16-17, 2010 New York City, United States American Association for Cancer Research (AACR) 101st Annual Meeting 2010 April 17-21, 2010 Washington, DC, United States BIT’s 3rd Annual World Cancer Congress 2010 – Breast Cancer Conference April 25-27, 2010 Shanghai, China IMPAKT Breast Cancer Conference May 6-8, 2010 Brussels, Belgium Breast Cancer Research 2010 Conference May 18, 2010 London, United Kingdom American Society of Clinical Oncology (ASCO) Annual Meeting 2010 June 4-8, 2010 Chicago, United States Gordon Research Conference: Mammary Gland Biology June 6-11, 2010 Lucca (Barga), Italy 12th Milan Breast Cancer Conference June 16-18, 2010 Milan, Italy The 21st Meeting of the European Association for Cancer Research (EACR) June 26-29, 2010 Oslo, Norway United Kingdom National Stem Cell Network (UKNSCN) Third Annual Scientific Conference July 12-14, 2010 Nottingham, United Kingdom 2010 World Cancer Congress August 18-21, 2010 Shenzhen, China 15th Congress of the European Society of Surgical Oncology (ESSO) September 15-17, 2010 Bordeaux, France 35th European Society for Medical Oncology (ESMO) Congress October 8-12, 2010 Milan, Italy 6th National Cancer Research Institute (NCRI) Conference November 7-10, 2010 Liverpool, United Kingdom JOB OPPORTUNITIES Recruit Top Talent Reach more than 11,000 potential candidates by posting your organization’s career opportunities with Cell Therapy News. Visit here to post your career opportunities. Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.
Have we missed an important article or publication in Mammary Cell News? Click here to submit! |
| |
|